A Wireless Cytosensor Based on a Bionic Dandelion Isothermal Amplification System for Ultrasensitive Detection of
Yafei Fu1, Yiling Li1, Zhihe Long2
1Department of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
ACS Nano
|June 23, 2025
Summary
A novel wireless cytosensor enhances circulating tumor cell (CTC) detection using a bionic dandelion isothermal amplification system (BDIAS) and wireless lateral flow immunoassay (LFIA). This system offers high sensitivity and simplicity for clinical oncology applications.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Accurate detection of circulating tumor cells (CTCs) is crucial for cancer management but faces challenges in sensitivity, cost, and complexity.
- Existing methods for CTC detection often have limitations that hinder widespread clinical adoption.
Purpose of the Study:
- To develop a sensitive, cost-effective, and operationally simple wireless cytosensor for accurate CTC detection.
- To leverage a novel bionic dandelion isothermal amplification system (BDIAS) and wireless lateral flow immunoassay (LFIA) for enhanced detection capabilities.
Main Methods:
- Development of a BDIAS integrating DNA walkers, nonlinear DNA self-assembly, and AuFe Janus nanoparticles for high amplification efficiency.
- Integration of BDIAS with wireless LFIA technology, including a wireless fluorescence strip analyzer and smartphone for rapid signal detection.
- Validation of the wireless cytosensor using whole-blood samples, assessing sensitivity, specificity, reproducibility, and anti-interference capabilities.
Main Results:
- The BDIAS achieved a 6.72-fold enhancement in amplification efficiency compared to traditional isothermal amplification systems (TIASs).
- The wireless cytosensor demonstrated an ultralow detection limit of 1.58 cells/mL.
- The system provided rapid (1-second) and precise detection with superior specificity and reproducibility, successfully detecting CTCs in whole blood.
Conclusions:
- The developed wireless cytosensor offers a highly sensitive, specific, and simple method for CTC detection.
- The synergistic integration of BDIAS and wireless LFIA technology shows significant promise for advancing clinical oncology diagnostics.
- This innovative approach addresses key limitations in current CTC detection, paving the way for improved cancer patient management.
Keywords:
Circulating tumor cellsCytosensorDNA self-assemblyIsothermal amplificationLateral flow immunoassay

